P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study

被引:0
|
作者
Lee, Seung-Yul [1 ]
机构
[1] CHA Bundang Med Ctr, Seongnam, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-44
引用
收藏
页码:B18 / B18
页数:1
相关论文
共 50 条
  • [22] P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
    Gragnano, Felice
    Capolongo, Antonio
    Calabro, Paolo
    CURRENT VASCULAR PHARMACOLOGY, 2024, 22 (01) : 1 - 4
  • [23] Monotherapy with a P2Y12 inhibitor or aspirin for patients with established atherosclerosis: an updated meta-analysis
    Cannata, Francesco
    Chiarito, Mauro
    Sanz-Sanchez, Jorge
    Cao, Davide
    Sturla, Matteo
    Regazzoli, Damiano
    Reimers, Bernhard
    Condorelli, Gianluigi
    Ferrante, Giuseppe
    Stefanini, Giulio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [24] Monotherapy with a P2Y12 inhibitor or aspirin for patients with established atherosclerosis: an updated meta-analysis
    Cannata, Francesco
    Chiarito, Mauro
    Sanz-Sanchez, Jorge
    Cao, Davide
    Sturla, Matteo
    Regazzoli, Damiano
    Reimers, Bernhard
    Condorelli, Gianluigi
    Ferrante, Giuseppe
    Stefanini, Giulio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [25] Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
    Ali Ayoub
    Karnika Ayinapudi
    Ahmed Al-Ogaili
    Muhammad Siyab Panhwar
    Wael Dakkak
    Thierry LeJemtel
    American Journal of Cardiovascular Drugs, 2021, 21 : 153 - 163
  • [26] Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis
    Nicolas, Johny
    Dangas, George
    Chiarito, Mauro
    Pivato, Carlo A.
    Spirito, Alessandro
    Cao, Davide
    Giustino, Gennaro
    Beerkens, Frans
    Camaj, Anton
    Vogel, Birgit
    Sartori, Samantha
    Yamamoto, Ko
    Kimura, Takeshi
    Kim, Byeong-Keuk
    Baber, Usman
    Mehran, Roxana
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (03) : 240 - 250
  • [27] Optimizing platelet P2Y12 inhibition for patients undergoing PCI
    Steinhubl, Steven
    Roe, Matthew T.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (02): : 188 - 203
  • [28] Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration
    Chandrasekhar, J.
    Kalkman, D. N.
    Aquino, M.
    Baber, U.
    Sartori, S.
    Woudstra, P.
    Beijk, M. A.
    Tijssen, J.
    Koch, K. T.
    Dangas, G. D.
    Colombo, A.
    De Winter, R. J.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 331 - 332
  • [29] Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis
    Komosal, Anna
    Lesiak, Maciej
    Krasinski, Zbigniew
    Grygier, Marek
    Siniawski, Andrzej
    Skorupski, Wlodzimierz
    Olasinska-Wgniewska, Anna
    Pyda, Malgorzata
    Araszkiewicz, Aleksander
    Mitkowski, Przemyslaw
    Grajek, Stefan
    Mularek-Kubzdela, Tatiana
    Hengstenberg, Christian
    Siller-Matula, Jolanta M.
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (06) : 1000 - 1020
  • [30] Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
    Ayoub, Ali
    Ayinapudi, Karnika
    Al-Ogaili, Ahmed
    Panhwar, Muhammad Siyab
    Dakkak, Wael
    LeJemtel, Thierry
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (02) : 153 - 163